Hyris

Hyris is a biotech company that provides a portable platform for decentralized genetic analysis. Founded in London, UK, in October 2014 by Stefano Lo Priore, the company aims to democratize DNA and RNA testing by making it accessible in any setting. The founders brought over two decades of experience in the biomedical systems sector to the company. In January 2024, Hyris integrated with Ulisse Biomed, an Italian publicly traded biotech company, through a reverse take-over to form a new international group. Stefano Lo Priore, Hyris's founder, became the Chairman of the new UBM Group.

The company's core offering is the Hyris System™, an integrated platform that includes hardware, software, and reagents. The central hardware component is the bCUBE™, a miniaturized, portable device for real-time PCR and isothermal amplification of nucleic acids. This device connects to the Hyris bAPP™, a cloud-based software portal for device control, data management, and AI-driven automated interpretation of results. The system is completed by bKITs™, which are validated reagent sets for specific genetic analyses, such as detecting pathogens or certifying botanical species. The business model involves both closed-platform solutions developed internally and an open-platform approach that allows third-party kit developers and researchers to use the Hyris System™ to create and deploy their own tests. This creates a marketplace for genetic testing, serving industries such as healthcare, diagnostics, agrifood, and nutraceuticals. Clients range from small research centers to large corporations.

Keywords: genetic analysis, portable diagnostics, real-time PCR, decentralized testing, biotech, nucleic acid testing, IoT diagnostics, molecular diagnostics, agrifood testing, environmental screening, qPCR device, AI-driven analysis, food safety testing, Hyris System, bCUBE, life sciences, DNA analysis, RNA detection, point-of-care testing, cloud software platform